InsideArbitrage Event Driven Monitor – January 22, 2024

Merger Arbitrage

1. KAMN: The acquisition of Kaman Corporation (KAMN) by Arcline Investment Management for a closing value of approximately $1.8 billion or $46 per share in cash.
2. ICVX: Icosavax (ICVX) and AstraZeneca (AZN) withdrew its filing for HSR approval and refiled a new HSR Act notification.  The waiting period under the HSR Act is set to expire on February 16, 2024.
3. CNSL: Consolidated Communications (CNSL)  announced that Institutional Shareholder Services  has recommended that Consolidated shareholders vote “FOR” the proposed acquisition of the company by affiliates of Searchlight Capital Partners and British Columbia Investment Management.

You can check out new deals, all deal updates, and spreads on active deals in our Merger Arbitrage Tool for premium members here.

Only plus or premium subscribers can access this post. Subscribe today.